Yeast Colonization and Drug Susceptibility Pattern in the Pediatric Patients With Neutropenia

Background: pediatric patients with neutropenia are vulnerable to invasive candida infections. candida is the primary cause of fungal infections, particularly in immunosuppressed patients. candida albicans has been the most common etiologic agent of these infections, affecting 48% of patientsobjectives: the aim of this study was to identify candida spp. isolated from children with neutropenia and determine the antifungal susceptibility pattern of the isolated yeasts.patients and methods: in this study 188 children with neutropenia were recruited, fungal surveillance cultures were carried out on nose, oropharynx, stool, and urine samples. identification of candida strains was performed using germ tube and chlamydospore production tests on an api 20 c aux system. susceptibility testing on seven antifungal agents was performed using the agar-based e-test method.results: a total of 229 yeasts were isolated. among those, c. albicans was the most common species followed by c. krusei, c. parapsilosis, c. glabrata, c. tropicalis, c. famata, c. dubliniensis, c. kefyr, and other candida species. c. glabrata was the most resistant isolated yeasts, which was 70% resistant to fluconazole and 50% to itraconazole, 7.5% to amphotericin b and 14% to ketoconazole. all the tested species were mostly sensitive to caspofungin.conclusions: knowledge about the susceptibility patterns of colonized candida spp. can be helpful for clinicians to manage pediatric patients with neutropenia. in this study, caspofungin was the most effective antifungal agent against the colonized candida spp. followed by conventional amphotericin b.